Country overview

Macro-economic and population profile[1]

GDP per capita (USD) (2016) 779.9
Inflation, GDP deflator (annual %) (2016) 1.5
Agriculture, value added (% of GDP) (2016) 42
Industry value added (% of GDP) (2016) 18
Services value added (% of GDP) (2016) 40
Foreign Direct Investment, net inflows (Balance of Payments, current USD) (millions) (2016) 126
Country population (2016) 18.5 million
Poverty headcount ratio at national poverty lines (% of population) (2016) 43.6 (2010)
Urban population growth (annual %) (2016) 4.9
World Bank ease of doing business ranking (out of 190 countries)[2] 143

Malaria burden and funding profile[3]

Estimated number of malaria cases (2016) 7,910,000
Malaria incidence/1,000 population at risk (2015) 448
Key national malaria control targets Reduce malaria mortality to near zero and malaria morbidity by at least 75% as compared to 2000 levels.
Total need (essential commodities + supporting interventions) (2018-2020) (USD) Not available[4]
Total committed (essential commodities + supporting interventions) (2018-2020) (USD) Not available
Total gap in funding (essential commodities + supporting interventions) (2018-2020)(USD) Not available

Sources of funding:


Overview of country economy and private sector landscape

After independence from France in 1960, Mali has suffered droughts, rebellions, a coup and 23 years of military dictatorship until democratic elections in 1992. It is one of the world's poorest countries, ranking 175th out of 187 in the United Nations Human Development Index.

It currently has a highly undiversified economy, with eighty percent of the population relying on traditional agriculture or fisheries. Cotton, gold, and livestock comprise 80%-90% of total export earnings in Mali.[5]

The scope and scale of private sector activities in malaria or health in Mali are difficult to identify given the lack of publicly available information.

In 2015, with the aim of strengthening the link between Mali’s National Malaria Control Program and private-sector pharmacies, USAID’s Systems for Improved Access to Pharmaceuticals and Services (SIAPS) programme conducted a survey to determine the feasibility of expanding access to malaria testing and treatment through private pharmacies. The survey results supported increased engagement with private pharmacies in confirming suspected malaria cases and providing appropriate treatment.[6]

[1] Sources: World Bank Development Indicators, accessed at: on 17th June 2018; and World Bank Doing Business Reports, accessed at on 17th June 2018.

[2] A ranking of 1 would equate to the highest ease of doing business, with a regulatory environment conducive to the starting and operation of a local firm.

[3] Sources: World Malaria Report 2017, accessed at on 5th June 2018; and Roll Back Malaria Funding Gap Analysis 2017, accessed at on on 5th June 2018.

[4] Funding data and projections for Ghana were not available in the RBM gap analysis data, accessed at: on 15th June 2018.

[5] World Bank: Mali Country Overview.

[6] USAID. Expanding access to RDTs and ACTs through private sector pharmacies in Mali. 2015. Accessed at on June 14th 2018.